JFrog stock rises as Cantor Fitzgerald maintains Overweight rating after strong Q2
USA Compression Partners, LP (NYSE:USAC), a company currently valued at $3.2 billion and showing strong momentum with a 26% return over the past six months, announced the appointment of Julie A. McEwen as Vice President and Controller, effective March 4, 2025. The company’s board of directors confirmed the decision on February 27, 2025, also designating McEwen as the principal accounting officer. According to InvestingPro analysis, USAC maintains a "GOOD" overall financial health score.
McEwen, 41, has a long-standing history with the company, having served as Controller since July 2014. Her experience extends prior to her tenure at USA Compression, with a background in public accounting at Deloitte. She holds both a Bachelor of Business Administration in accounting and a Master in Professional Accounting from the University of Texas at Austin, and is a Certified Public Accountant. Under the company’s current leadership, USAC has maintained consistent dividend payments for 8 consecutive years, currently offering a significant 7.8% yield.
The appointment comes with no changes to McEwen’s compensation package, and there are no reported familial ties or transactional conflicts between McEwen and other company directors or executive officers. Furthermore, the company disclosed no arrangements or understandings with other persons regarding McEwen’s selection.
This organizational update follows standard corporate governance practices and is disclosed in compliance with SEC regulations. The information regarding these corporate changes is based on the latest 8-K filing with the Securities and Exchange Commission.
In other recent news, USA Compression Partners has seen a series of notable developments. Moody’s Ratings upgraded the company’s Corporate Family Rating to Ba3 from B1, citing increased profitability and improved credit metrics. The company’s strategic focus on capital spending moderation is expected to help it approach cash flow breakeven by 2025. Meanwhile, Citi raised its price target for USA Compression to $27, maintaining a Neutral stance, reflecting anticipated growth in the company’s backlog and long-term cash flow starting in 2026. S&P Global also revised its outlook for the company to stable from positive, following a more conservative earnings guidance for 2025 and expected leverage remaining above 4.0x. Raymond (NSE:RYMD) James increased its price target to $30, maintaining an Outperform rating, influenced by the company’s strong performance in the fourth quarter and favorable market conditions. Additionally, Stifel raised its price target to $28 while keeping a Hold rating, noting the company’s robust 2025 EBITDA projection and strategic operational enhancements. These recent developments highlight USA Compression Partners’ ongoing efforts to strengthen its financial standing and operational capabilities amidst changing market dynamics.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.